Co-Dafalgan, Brausetabletten - 16 Tablette(n) Swissmedic Key 47353025 Registration Holder UPSA Switzerland AG Name Co-Dafalgan, Brausetabletten Date of registration 03.12.1986 Introduction of Sequence 03.12.1986 ATC-Classification Codeine and Paracetamol (N02AJ06) Revision date 24.01.2006 WHO WHO-DDD Valid until Index Therapeuticus (BSV) 01.01.20. Show package size 16 Tablette(n) Index Therapeuticus (Swissmedic) 01.01.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 2.27 Limitation No Deductible 10 % Consumer price 11.70 Feedback FB GTIN 7680473530254 Medication Code SynthetikaA Pharmacode 1353522 Disponibility
Composition paracetamolum 500 mg, codeini phosphas hemihydricus 30 mg, natrii hydrogenocarbonas, natrii carbonas, acidum citricum, natrii docusas, povidonum, aromatica, sorbitolum 300 mg, aspartamum 30 mg, E 211 58.5 mg pro compresso corresp. natrium 384.7 mg. Teilbarkeit Teilbar Nein Auflösbar oder suspendierbar Ja Zermörsebar -- Öffnen von Kapseln -- Bemerkungen / Alternativen Quellen
th_part Galenic Form Effervescent tablets Active Agent Dose Codeine Phosphate Hemihydrate 30 mg Paracetamol 500 mg
BAG: Active Agent Dose Codeine Phosphate Hemihydrate 30 mg Paracetamol 500 mg
Inactive agents Dose additional_information Citric Acid Aromatica Aspartame 30 mg E 211 58.5 mg conserv. Sodium Carbonate Natrii Docusas Sodium Hydrogen Carbonate Povidone Pro Compresso Sorbitol 300 mg
Source Data was imported : 14.04.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
